Alnylam Pharmaceuticals, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| A1LN34.SA | ARWR | IONS | BBIO | ROIV | 4591.T | |
|---|---|---|---|---|---|---|
| Market cap | 123.54B | 8.71B | 6.67B | 15.17B | 27.61B | 3.39B |
| P/E (TTM) | 8.9 | — | — | — | — | — |
| Forward P/E | — | -12.4 | -35.0 | -225.0 | -27.5 | -1.1 |
| Price/book | 6.8 | 18.7 | 15.1 | -5.9 | 6.5 | 1.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −62.24% | +55.68% | −45.82% | +24.17% | +85.85% | −29.21% |
| Today | +3.64% | +3.56% | −0.67% | +5.21% | +6.08% | −4.76% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All A1LN34.SA news ›Alnylam Pharmaceuticals authorizes $1B share repurchase program
TradingView Alnylam Pharmaceuticals authorizes $1B share repurchase program - Alnylam Pharmaceuticals announced that its board has authorized a $1B share repurchase program. - The company expects to repurchase ~$500M worth of shares by
Alnylam Pharmaceuticals, Inc. $ALNY Stock: VIRGINIA RETIREMENT SYSTEMS ET Al Boosts Stake
Posted by Danessa Lincoln on Nov 1st, 2026 Check Out Our Latest Report on ALNY Here are the key news stories impacting Alnylam Pharmaceuticals this week: Alnylam Pharmaceuticals, Inc is a biopharmaceutical company focused on developing and…
Alnylam Pharmaceuticals (NASDAQ:ALNY) Stock Gets Price Target Trim from Needham & Company LLC
Posted by Kim Johansen on Nov 1st, 2026 Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price reduced by Needham & Company LLC from $357.00 to $243.00 in a report released on Thursday morning,Benzinga reports. Needham &…
Alnylam Pharmaceuticals, Inc. (ALNY) RNAi Roundtable: Exon 1 Targeting With Brezosiran for Huntington's Disease - Slideshow
2026-10-30. The following slide deck was published by Alnylam Pharmaceuticals, Inc. The following slide deck was published by Alnylam Pharmaceuticals, Inc. in conjunction with this event. Q3: 2026-10-29 Earnings Summary
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Cut to $280.00 by Analysts at Royal Bank Of Canada
Posted by Danessa Lincoln on Oct 31st, 2026 Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target cut by Royal Bank Of Canada from $345.00 to $280.00 in a research report sent to investors on Friday,Benzinga reports.…
Alnylam Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Recent Period Progress
− Generated Third Quarter 2026 Global Net Product Revenues of $1,292 Million (52% Growth Compared with Q3 2025), Driven Primarily by Total TTR Revenues of $1,150 Million (59% Growth Compared with Q3 2025) – − Expands Target Enrollment in…
Alnylam Pharmaceuticals, Inc. 2026 Q3 - Results - Earnings Call Presentation
2026-10-30. The following slide deck was published by Alnylam Pharmaceuticals, Inc. The following slide deck was published by Alnylam Pharmaceuticals, Inc. in conjunction with their 2026 Q3 earnings call. Q3: 2026-10-29 Earnings Summary
Alnylam Pharmaceuticals, Inc. $ALNY Stock Sold by Robeco Institutional Asset Management B.V.
Here are the key news stories impacting Alnylam Pharmaceuticals this week: Get Our Latest Stock Analysis on Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc is a biopharmaceutical company focused on developing and commercializing…
34,533 Alnylam Pharmaceuticals, Inc. $ALNY Shares Sold by Curated Wealth Partners LLC
Posted by Defense World Staff on Oct 18th, 2026 Read Our Latest Research Report on ALNY Alnylam Pharmaceuticals, Inc is a biopharmaceutical company focused on developing and commercializing medicines based on RNA interference (RNAi), a…
Alnylam Pharmaceuticals, Inc. $ALNY Shares Newly Acquired by First Citizens Bank & Trust Co.
Posted by Defense World Staff on Oct 17th, 2026 First Citizens Bank & Trust Co. bought a new position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) during the 3rd quarter, according to its most recent disclosure with the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- themarketsdaily.com8
- seekingalpha.com7
- defenseworld.net3
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.